Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Related Content:
Coping With a Rare Cancer Diagnosis, Like GIST
Refining Treatment Approaches and Advancements in High-Risk Melanoma
Celebrating My Clean Bill of Health After Cancer
Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer
